Research and Markets - Global Radiosurgery and Radiotherapy Robotics Market to Grow at a CAGR of 6.4%, 2017-2021 with Accuray, Brainlab, Elekta & Varian Medical Systems Dominating

DUBLIN, Apr. 11, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Radiosurgery and Radiotherapy Robotics Market 2017-2021" report to their offering.

The global radiosurgery and radiotherapy robotics market to grow at a CAGR of 6.48% during the period 2017-2021.

The report, Global Radiosurgery and Radiotherapy Robotics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in market is use for extracranial radiosurgery treatments. Extracranial radiosurgery is expected to gain traction during the forecast period as a new treatment option to treat tumors of the liver, lung, and spine, and other complicated cases. CyberKnife technology is especially useful in treating tumors with sub-millimeter precision. Other treatments require metal frames for tumors of brain, head, and neck, and body casts to limit movement during treatments of lung, liver, pancreas and kidney. Also, the treatment of prostate involves injection of hardening chemicals or rectal balloons. On the other hand, robotic systems like CyberKnife have the ability to conduct radio-surgeries without the requirement of any restricting frames, while ensuring greater accuracy in targeting a moving tumor.

According to the report, one driver in market is increase in cancer cases and re-treatments. A growing number of physicians and hospitals, which specialize in oncology treatments, are expected to adopt radiosurgery and radiotherapy for treatment of lesions and tumors. This is because these treatments enable a shorter treatment time and greater patient throughput, which ensures that the patient is immobilized on the treatment couch for a shorter period and allows patients to resume regular daily life soon.

For physicians, it implies that there is a lesser probability of the tumor moving during the treatment, thus reducing throughput. This can eventually result in a higher number of patients being treated on a daily basis, hence greater revenue. Another major driver, especially for radiosurgery, is the rise in the cases of re-treatment and relapse that makes radiosurgery a preferred choice as it involves a precise dose distribution, thus limiting the exposure of healthy tissues to excessive radiation.

Key vendors

• Accuray
• Brainlab
• Elekta
• Varian Medical Systems
  

Other prominent vendors

• Best Theratronics
• Huiheng Medical
• MASEP Medical Science Technology Development
• Others
  

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation type of radiation beam used

PART 07: Geographical segmentation

PART 08: Decision framework

PART 09: Drivers and challenges

PART 10: Market trends

PART 11: Vendor landscape

PART 12: Key vendor analysis

PART 13: Key takeaways

PART 14: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/d48fbj/global

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]